Targeting neddylation pathway with MLN4924 (Pevonedistat) induces NOXA-dependent apoptosis in renal cell carcinoma.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Biochemical and Biophysical Research Communications - BBRC

• Publication date

  2017-09-02

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.bbrc.2017.06.179PMID 28669728
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Neddylation Inhibition Activates the Extrinsic Apoptosis Pathway through ATF4–CHOP–DR5 Axis in Human Esophageal Cancer Cells

  2016cited by this paper
• Suppression of glioblastoma by targeting the overactivated protein neddylation pathway.

  2015cited by this paper
• MLN4924 induces Noxa upregulation in acute myelogenous leukemia and synergizes with Bcl-2 inhibitors

  2015cited by this paper
• Phase I Study of the Investigational NEDD8-Activating Enzyme Inhibitor Pevonedistat (TAK-924/MLN4924) in Patients with Advanced Solid Tumors

  2015cited by this paper
• Phase I Study of the Novel Investigational NEDD8-Activating Enzyme Inhibitor Pevonedistat (MLN4924) in Patients with Relapsed/Refractory Multiple Myeloma or Lymphoma

  2015cited by this paper
• Targeting protein neddylation with an NEDD8-activating enzyme inhibitor MLN4924 induced apoptosis or senescence in human lymphoma cells

  2015cited by this paper
• Suppression of tumor angiogenesis by targeting the protein neddylation pathway

  2014cited by this paper
• Neddylation pathway is up-regulated in human intrahepatic cholangiocarcinoma and serves as a potential therapeutic target

  2014cited by this paper
• The Nedd8-Activating Enzyme Inhibitor MLN4924 Thwarts Microenvironment-Driven NF-κB Activation and Induces Apoptosis in Chronic Lymphocytic Leukemia B Cells

  2014cited by this paper
• Overactivated neddylation pathway as a therapeutic target in lung cancer.

  2014cited by this paper
• The covalent modifier Nedd8 is critical for the activation of Smurf1 ubiquitin ligase in tumorigenesis

  2014cited by this paper
• c-Cbl-mediated neddylation antagonizes ubiquitination and degradation of the TGF-β type II receptor.

  2013cited by this paper
• FBW7 regulates endothelial functions by targeting KLF2 for ubiquitination and degradation

  2013cited by this paper
• Novel DNA damage checkpoints mediating cell death induced by the NEDD8-activating enzyme inhibitor MLN4924.

  2013cited by this paper
• WEE1 accumulation and deregulation of S-phase proteins mediate MLN4924 potent inhibitory effect on Ewing sarcoma cells

  2013cited by this paper
• Negative regulation of NEDD8 conjugation pathway by novel molecules and agents for anticancer therapy.

  2013cited by this paper
• The Nedd8-activating enzyme inhibitor MLN4924 induces autophagy and apoptosis to suppress liver cancer cell growth.

  2012cited by this paper
• Targeting Cullin-RING ligases by MLN4924 induces autophagy via modulating the HIF1-REDD1-TSC1-mTORC1-DEPTOR axis

  2012cited by this paper
• Induction of autophagy and senescence by knockdown of ROC1 E3 ubiquitin ligase to suppress the growth of liver cancer cells

  2012cited by this paper
• Clinical, molecular, and genetic correlates of lymphatic spread in clear cell renal cell carcinoma.

  2012cited by this paper
• Murine double minute 2 regulates Hu antigen R stability in human liver and colon cancer through NEDDylation

  2012cited by this paper
• Cancer: Mdm2-regulated stabilization of HuR by neddylation in HCC and colon cancer—a possible target for therapy

  2012cited by this paper
• Radiosensitization of human pancreatic cancer cells by MLN4924, an investigational NEDD8-activating enzyme inhibitor.

  2012cited by this paper
• MLN4924: a novel first-in-class inhibitor of NEDD8-activating enzyme for cancer therapy

  2012cited by this paper
• Targeting neddylation in cancer therapy.

  2012cited by this paper
• Targeting protein neddylation: a novel therapeutic strategy for the treatment of cancer

  2011cited by this paper
• Induction of p21-dependent senescence by an NAE inhibitor, MLN4924, as a mechanism of growth suppression.

  2011cited by this paper
• Inactivation of SAG E3 Ubiquitin Ligase Blocks Embryonic Stem Cell Differentiation and Sensitizes Leukemia Cells to Retinoid Acid

  2011cited by this paper
• SCF E3 ubiquitin ligases as anticancer targets.

  2011cited by this paper
• Epidemiology and risk factors for kidney cancer

  2010cited by this paper
• The NEDD8 Conjugation Pathway and Its Relevance in Cancer Biology and Therapy.

  2010cited by this paper
• NEDD8-targeting drug MLN4924 elicits DNA rereplication by stabilizing Cdt1 in S phase, triggering checkpoint activation, apoptosis, and senescence in cancer cells.

  2010cited by this paper
• Validation of SAG/RBX2/ROC2 E3 Ubiquitin Ligase as an Anticancer and Radiosensitizing Target

  2010cited by this paper
• MLN4924, a NEDD8-activating enzyme inhibitor, is active in diffuse large B-cell lymphoma models: rationale for treatment of NF-{kappa}B-dependent lymphoma.

  2010cited by this paper
• An inhibitor of NEDD8-activating enzyme as a new approach to treat cancer

  2009cited by this paper
• ERAD inhibitors integrate ER stress with an epigenetic mechanism to activate BH3-only protein NOXA in cancer cells

  2009cited by this paper
• ROC1/RBX1 E3 ubiquitin ligase silencing suppresses tumor cell growth via sequential induction of G2-M arrest, apoptosis, and senescence.

  2009cited by this paper
• Contemporary Epidemiology of Renal Cell Cancer

  2008cited by this paper
• Novel substrates and functions for the ubiquitin-like molecule NEDD8.

  2008cited by this paper
• Structural insights into NEDD8 activation of cullin-RING ligases: conformational control of conjugation.

  2008cited by this paper
• Function and regulation of protein neddylation

  2008cited by this paper
• Renal cell carcinoma: new developments in molecular biology and potential for targeted therapies.

  2007cited by this paper
• Direct interactions between NEDD8 and ubiquitin E2 conjugating enzymes upregulate cullin-based E3 ligase activity

  2007cited by this paper
• Drug discovery in the ubiquitin–proteasome system

  2006cited by this paper
• Function and regulation of cullin–RING ubiquitin ligases

  2005cited by this paper
• Neddylation and deneddylation regulate Cul1 and Cul3 protein accumulation

  2005cited by this paper
• Mdm2-mediated NEDD8 conjugation of p53 inhibits its transcriptional activity.

  2004cited by this paper
• Epidemiology and risk factors of kidney cancer.

  2004cited by this paper

• Pevonedistat targeting NEDDylation activating enzyme for human diseases: Underlying mechanisms, clinical studies, and future directions.

  2026cites this paper
• SUMOylation and NEDDylation in kidney diseases.

  2025cites this paper
• Discovery of small molecule inhibitors of neddylation catalyzing enzymes for anticancer therapy.

  2024cites this paper
• Function, mechanism and drug discovery of ubiquitin and ubiquitin-like modification with multiomics profiling for cancer therapy

  2023cites this paper
• SOMCL-19-133, a novel, selective, and orally available inhibitor of NEDD8-activating enzyme (NAE) for cancer therapy

  2022cites this paper
• E1 Enzymes as Therapeutic Targets in Cancer

  2021cites this paper
• Advances in Cancer Treatment by Targeting the Neddylation Pathway

  2021cites this paper
• Targeting Protein Neddylation for Cancer Therapy.

  2020cites this paper
• Pevonedistat (MLN4924): mechanism of cell death induction and therapeutic potential in colorectal cancer

  2020cites this paper
• Pevonedistat (MLN4924): mechanism of cell death induction and therapeutic potential in colorectal cancer

  2020cites this paper
• An alternative and efficient synthesis of MLN4924, a selective NEDD8 inhibitor

  2019cites this paper
• Inactivation of SAG or ROC1 E3 Ligase Inhibits Growth and Survival of Renal Cell Carcinoma Cells: Effect of BIM

  2019influential citation
• Autophagy regulates apoptosis by targeting NOXA for degradation.

  2018cites this paper
• Neural precursor cell expressed, developmentally downregulated 8 promotes tumor progression and predicts poor prognosis of patients with bladder cancer

  2018cites this paper
• Protein neddylation and its alterations in human cancers for targeted therapy.

  2018cites this paper